# Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin

> **NCT03483792** · — · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 58 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **BIOLOGICAL:** Plasma dosage
- **GENETIC:** placental biopsy

## Key facts

- **NCT ID:** NCT03483792
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-20
- **Primary completion:** 2022-06-02
- **Final completion:** 2022-06-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03483792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03483792, "Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03483792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*